Medication info
Reed San Plus Tablets

Reed San Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
Pale orange oval film-coated tablet
Packaging
4 tablets/PTP
Approval status
Active

MFDS item code 201700469 · Approved 2017.01.25 · Insurance code 662503610

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Take 1 tablet orally once weekly. Older adults: Since the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people, no dosage adjustment is necessary. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This medicine is contraindicated in patients with severe renal impairment with a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after eating food or drinking beverages. Take this medicine in an upright position with a sufficient amount of plain water (170 ~ 230ml) to help it reach the stomach easily and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Do not lie down for at least 30 minutes after taking this medicine. If calcium and vitamin D intake from food is insufficient, patients should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic disease) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Children: The safety and efficacy in children and growing adolescents have not been established.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Take 1 tablet orally once weekly. Older adults: Since the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people, no dosage adjustment is necessary. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30ml/min or more. This medicine is contraindicated in patients with severe renal impairment with a creatinine clearance below 30ml/min. Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after eating food or drinking beverages. Take this medicine in an upright position with a sufficient amount of plain water (170 ~ 230ml) to help it reach the stomach easily and reduce the possibility of esophageal irritation. Taking it with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Do not lie down for at least 30 minutes after taking this medicine. If calcium and vitamin D intake from food is insufficient, patients should take supplements. Patients at increased risk of vitamin D deficiency (e.g., patients over 70 years of age, institutionalized patients, and patients with chronic disease) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides one week's supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Resume taking the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Children: The safety and efficacy in children and growing adolescents have not been established.

Precautions

This medication may irritate the stomach and esophagus; therefore, it should be taken with a sufficient amount of water and one should not lie down for at least 30 minutes after taking it. If symptoms such as esophagitis, esophageal ulcer, dysphagia, chest pain, or heartburn occur, discontinue use immediately and consult a physician. Patients with gastrointestinal diseases or problems with esophageal emptying should not take this medication, and patients with severely impaired kidney function should also not receive it. Taking this medication with drugs or beverages containing calcium, magnesium, iron, etc. can reduce its efficacy, so it is important to space out the administration. This medication may require supplementation of calcium and vitamin D, especially in patients receiving long-term steroid treatment, for whom additional supplementation is recommended. Rarely reported adverse effects include osteonecrosis of the jaw, severe skin reactions, and liver function abnormalities, so one should inform medical staff immediately if any unusual symptoms occur. Women who are pregnant or nursing should exercise caution when using this medication and decide to take it after consulting with a physician. Elderly patients may use it without special dosage adjustments, but safety in children has not been established. Overdose may result in hypocalcemia, so it is crucial to adhere to the prescribed dosage, and patients should visit a medical institution immediately if any unusual symptoms occur. This medication must be kept out of reach of children, and it is advisable not to transfer it to other containers.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • bleeding
  • gastric ulcer
  • duodenitis
  • glossitis
  • hypocalcemia
Show 102 more
  • hypophosphatemia
  • infection
  • low back pain
  • pain
  • abdominal pain
  • throat pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • tension increase
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • pandemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • fainting
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • polydipsia
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • osteoarthritis
  • limb pain
  • muscle rigidity
  • cervical pain
  • weakness
  • fever
  • falling
  • dizziness
  • bronchitis
  • sinusitis
  • increased coughing
  • heartburn
  • epigastric pain
  • facial swelling
  • hair loss
  • dysosmia
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • jaw necrosis
  • liver function impairment
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain a room temperature between 1 degree and 30 degrees Celsius. This will help to preserve the efficacy and safety of the medication for a longer period.

Appearance and packaging

Appearance

Pale orange oval film-coated tablet

Package unit

4 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.